CEI HCV/DUH Training Intake Form Question Title * 1. Today's Date Date / Time Date Question Title * 2. Your first name, last name and title Question Title * 3. Your email address Question Title * 4. Your phone number Question Title * 5. Organization name Question Title * 6. Your organization's address Question Title * 7. Has your organization hosted a CEI training in the past? Yes No Unsure Question Title * 8. What type of training program would you like to schedule? Single training Multiple trainings Question Title * 9. How many staff do you expect to attend this training program? Question Title * 10. Who is the audience for the proposed training? MDs RNs PAs NPs Pharmacists Nurse Midwives Dentists Dental Hygienists Other Question Title * 11. We provide Continuing Education (CE) credit to MDs, PAs, NPs, Dental Hygienists, Dentists, Pharmacists, RNs, and Nurse Midwives in New York State. Would you be interested in offering CE to your attendees? Yes No Question Title * 12. Which specific course(s) would you like for your CEI training? (All trainings are one hour and 1 CE credit [CNE, CME or CPE], unless stated otherwise) Achieved SVR, What's Next? HCV Post Treatment Management Antiracism and Harm Reduction Buprenorphine Prescribing for Beginners Caring for Pregnant Persons with Substance Use Disorder: Shifting from Criminalization to Chronic Disease Management Case Studies on Pregnant and Postpartum Persons with Opioid Use Disorder Cirrhosis in Patients with Hepatitis C: What Clinicians Need to Know Clinical Approaches to Medical Cannabis Engaging LGBTQ+ People who Use Drugs: Cultural Responsiveness and Beyond Hepatitis C among Women of Childbearing Age Hepatitis B and C: Coinfection & Reactivation Hepatitis C & HIV Coinfection Hepatitis C and Alcohol Hepatitis C among Infants, Children and Adolescents Hepatitis C and Injection Drug Use Hepatitis C Care through Telemedicine to Promote Elimination Hepatitis C Reinfection Hepatitis C Testing and Pre-Treatment Evaluation Hepatitis C Treatment Linkage to Care, Adherence and Retention in HCV Treatment Models of Hepatitis C Telemedicine for People who Use Drugs: A Case-based Discussion Opioid Use Disorder in Women: Focusing on Pregnant Persons and Persons of Childbearing Age Pain Management for People who Use Opioids Plans of Safe Care (POSC): Developing POSC with a Patient-Centered Approach Stimulant Use Disorder: Clinical Practice Guidelines for the Primary Care Provider Stimulants: From Caffeine to Cocaine and Ecstasy Stimulants: From Crystal Methamphetamine to Bath Salts and Beyond Stimulants: Advanced Clinical Practicum Strategies to Prevent Overdose in New York State: A Harm Reduction Framework Substance Use, Pregnancy & Parenting: a Harm Reduction Approach Trauma Informed Care for People who Use Drugs Treating Medical Complications of Injection Drug Use Treatment of Alcohol Use Disorder: Clinical Practice Guidelines for the Primary Care Setting Universal Hepatitis C Screening among Pregnant Persons to Reduce Stigma and Advance Elimination Urine Drug Testing in Primary Care and Office Based Opioid Treatment Xylazine: What Clinicians Need to Know about 'Tranq' in Heroin and Fentanyl Question Title * 13. Due to the CEI CE accreditation process, we require at least 6 weeks between confirming the training date and implementing the training. What date(s)/time(s) are typically best for your organization/department to schedule trainings? (Please note: for trainings without CE, we require at least 2 weeks) Question Title * 14. Is there anything else you would like us to know? Done
